Enovis (ENOV)
(Delayed Data from NYSE)
$43.75 USD
-0.62 (-1.40%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $43.74 -0.01 (-0.02%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ENOV 43.75 -0.62(-1.40%)
Will ENOV be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ENOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENOV
5 Medical Info Systems Stock to Buy for a Stable Portfolio
Compelling Reasons to Hold on to HCA Healthcare (HCA) Stock
ENOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ensign Group (ENSG) Buys Facilities in Arizona & Colorado
Zacks Industry Outlook Highlights Hims & Hers Health, Enovis Corp and Health Catalyst
3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare
Other News for ENOV
Top 3 Health Care Stocks That Could Blast Off In June
August 16th Options Now Available For Enovis (ENOV)
Enovis initiated with neutral view at JPMorgan, here's why
Interesting ENOV Put And Call Options For April 2025
Alan Fournier's Strategic Moves in Q1 2024 Highlighted by Major Stake in Enovis Corp